Prominent Steatosis with Hypermetabolism of the Cell Line Permissive for Years of Infection with Hepatitis C Virus

• Kazuo Sugiyama ,

  * E-mail: sygiyamkz@a8.keio.jp

  Affiliation Center for the Study of Chronic Liver Diseases, Keio University School of Medicine, Tokyo, Japan

  ⨯
• Hirotoshi Ebinuma,

  Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

  ⨯
• Nobuhiro Nakamoto,

  Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

  ⨯
• Noriko Sakasegawa,

  Affiliation Graduate School, Keio University School of Medicine, Tokyo, Japan

  ⨯
• Yuko Murakami,

  Affiliation Division of Pharmacotherapeutics, Faculty of Pharmacy, Keio University, Tokyo, Japan

  ⨯
• Po-sung Chu,

  Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

  ⨯
• Shingo Usui,

  Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

  ⨯
• Yuka Ishibashi,

  Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

  ⨯
• Yuko Wakayama,

  Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

  ⨯
• Nobuhito Taniki,

  Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

  ⨯
• Hiroko Murata,

  Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

  ⨯
• Yoshimasa Saito,

  Affiliation Division of Pharmacotherapeutics, Faculty of Pharmacy, Keio University, Tokyo, Japan

  ⨯
• Masayoshi Fukasawa,

  Affiliation Department of Biochemistry and Cell Biology, National Institute of Infectious Disease, Tokyo, Japan

  ⨯
• Kyoko Saito,

  Affiliation Department of Biochemistry and Cell Biology, National Institute of Infectious Disease, Tokyo, Japan

  ⨯
• Yoshiyuki Yamagishi,

  Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

  ⨯
• Takaji Wakita,

  Affiliation Virology II, National Institute of Infectious Disease, Tokyo, Japan

  ⨯
• Hiroshi Takaku,

  Affiliation Department of Life and Environmental Sciences, Chiba Institute of Technology, Chiba, Japan

  ⨯
• Toshifumi Hibi,

  Affiliation Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan

  ⨯
• Hidetsugu Saito,

  Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, Division of Pharmacotherapeutics, Faculty of Pharmacy, Keio University, Tokyo, Japan

  ⨯
•  [ ... ],
• Takanori Kanai

  Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

  ⨯
• [ view all ]
• [ view less ]